Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · IEX Real-Time Price · USD
1.700
+0.420 (32.81%)
At close: Jul 19, 2024, 4:00 PM
1.570
-0.130 (-7.65%)
Pre-market: Jul 22, 2024, 9:08 AM EDT
Virpax Pharmaceuticals Employees
Virpax Pharmaceuticals had 7 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,412,771
Market Cap
8.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7 | 0 | - |
Dec 31, 2022 | 7 | 0 | - |
Dec 31, 2021 | 7 | 5 | 250.00% |
Dec 31, 2020 | 2 | 0 | - |
Dec 31, 2019 | 2 | - | - |
Related Stocks
Company Name | Employees |
---|---|
XWELL | 337 |
Syra Health | 162 |
Vivos Therapeutics | 123 |
Mainz Biomed B.V. | 71 |
Molecular Templates | 62 |
Organovo Holdings | 20 |
Kineta | 13 |
NLS Pharmaceutics AG | 7 |
VRPX News
- 11 days ago - Crude Oil Gains Over 1%; Virpax Pharmaceuticals Shares Spike Higher - Benzinga
- 11 days ago - Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why? - Benzinga
- 13 days ago - What's Going With Penny Stock Virpax Pharmaceuticals On Monday? - Benzinga
- 14 days ago - Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding - Business Wire
- 7 weeks ago - Virpax® Pharmaceuticals to Present at 2024 BIO International Convention - Business Wire
- 2 months ago - Virpax Announces Pricing of $2.25 Million Public Offering - Business Wire
- 2 months ago - Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments - Business Wire
- 2 months ago - Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™ - Business Wire